Ponchon P, Elghozi J L
Laboratory of Pharmacology, CNRS URA 1482, Faculty of Medicine Necker-E.M., Paris, France.
Eur J Pharmacol. 1996 Feb 15;297(1-2):61-70. doi: 10.1016/0014-2999(95)00721-0.
Spectral analysis was recently chosen to characterize the fast oscillations, depending on the autonomic nervous system, in heart rate and blood pressure variabilities. Humoral stimuli could impinge on the low-frequency domain of blood pressure variability since the time lag to humoral system activation is greater. This study was designed to analyse low-frequency components of short-term variability of blood pressure of conscious rats in conditions where humoral systems were activated. We studied rats with two-kidney, one-clip Goldblatt hypertension in which the blood pressure level was dependent upon the renin-angiotensin and kallikrein-kinin systems. Spectral powers of the systolic and diastolic blood pressure and heart rate were computed in the high (respiratory)-, mid (0.2-0.6 Hz)- and low (0.02-0.2 Hz)-frequency bands, as detected by the fast Fourier transform technique in consecutive 102-s stationary periods. Hypertensive rats exhibited a marked low-frequency component of systolic (+261%) and diastolic (+169%) blood pressure variabilities when compared to sham-operated animals. First, losartan, a selective non-peptide angiotensin AT1 receptor antagonist, reduced this low-frequency component (-44% and -25% for systolic and diastolic blood pressure). In a second series of hypertensive rats, HOE 140, D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin, a bradykinin B2 receptor antagonist, decreased the low-frequency component of systolic (-28%) and diastolic (-40%) blood pressure. Losartan, added after HOE 140, induced a supplementary decrease of the low-frequency component (-60% and -42% for systolic and diastolic blood pressure). After the combined blockade, the low-frequency components of systolic and diastolic blood pressure variabilities of the hypertensive rats were equivalent to those of the control rats. Two-kidney, one-clip hypertension was also associated with an elevation of the mid-frequency component of the systolic blood pressure (+55%). The administration of HOE 140 did not change this component while losartan, alone or added after HOE 140, led to an increase (around +100%) in mid-frequency oscillations of systolic blood pressure. The high-frequency oscillations of systolic blood pressure were increased by losartan in the two series of hypertensive rats. Losartan increased the mid-frequency component of heart rate variability in sham-operated rats while the heart rate variability was not modified during any of the treatment periods in two-kidney, one-clip rats. In conclusion, an increase in the low-frequency component of blood pressure variability was observed in a model of hypertension where the blood pressure is dependent upon humoral activities. The reduction of the slow fluctuations following the combined blockade of the kallikrein-kinin and the renin-angiotensin systems suggested the contribution of these humoral systems to this low-frequency component of blood pressure variability.
最近选择频谱分析来表征取决于自主神经系统的心率和血压变异性中的快速振荡。体液刺激可能会影响血压变异性的低频域,因为体液系统激活的时间滞后更长。本研究旨在分析在体液系统激活的条件下清醒大鼠短期血压变异性的低频成分。我们研究了双肾单夹Goldblatt高血压大鼠,其血压水平取决于肾素-血管紧张素和激肽释放酶-激肽系统。通过快速傅里叶变换技术在连续102秒的平稳期检测到的收缩压、舒张压和心率的频谱功率在高(呼吸)、中(0.2 - 0.6赫兹)和低(0.02 - 0.2赫兹)频段进行计算。与假手术动物相比,高血压大鼠的收缩压(+261%)和舒张压(+169%)变异性表现出明显的低频成分。首先,洛沙坦,一种选择性非肽类血管紧张素AT1受体拮抗剂,降低了这种低频成分(收缩压和舒张压分别降低-44%和-25%)。在第二组高血压大鼠中,HOE 140,D-精氨酸-[Hyp3,Thi5,D-Tic7,Oic8]缓激肽,一种缓激肽B2受体拮抗剂,降低了收缩压(-28%)和舒张压(-40%)的低频成分。在HOE 140之后添加洛沙坦,导致低频成分进一步降低(收缩压和舒张压分别降低-60%和-42%)。联合阻断后,高血压大鼠收缩压和舒张压变异性的低频成分与对照大鼠相当。双肾单夹高血压还与收缩压的中频成分升高(+55%)有关。给予HOE 140并没有改变这一成分,而洛沙坦单独使用或在HOE 140之后添加,导致收缩压的中频振荡增加(约+100%)。在两组高血压大鼠中,洛沙坦增加了收缩压的高频振荡。洛沙坦增加了假手术大鼠心率变异性的中频成分,而在双肾单夹大鼠的任何治疗期间心率变异性均未改变。总之,在血压取决于体液活动的高血压模型中,观察到血压变异性的低频成分增加。激肽释放酶-激肽系统和肾素-血管紧张素系统联合阻断后缓慢波动的减少表明这些体液系统对血压变异性的这种低频成分有贡献。